The National Institute for Biological Standards and Control (NIBSC) is a global leader in the standardisation and control of biological medicines. As part of the Medicines and Healthcare Products Regulatory Agency we are world leaders in supporting science and research and the regulation of medicines and medical devices, strengthening the support provided to the UK’s medicines industry.
NIBSC is the global leader in the field of biological standardisation, responsible for developing and producing over 90% of the International Standards
NIBSC can supply you with a wide range of biological standards, reference materials, samples and reagents including WHO International Standards, Influenza reagents, QC reagents, HIV/AIDS reagents.
NIBSC acts as the UK’s OMCL and the Institute performs batch release testing of biological medicines and vaccines for the European market.
NIBSC is involved in many aspects of the science concerning standardisation and control testing. In addition there is a considerable research effort to support these two areas.
Are you a batch release customer? NIBSC are undertaking a customer satisfaction survey with a focus on turnaround times for control testing. We greatly value your views and the information you provide will help us improve our future control testing (OCABR) work.
The NIBSC website is going to be updated to better meet your needs. To find out more about you and how you use the website we have put together a short survey and would greatly value your feedback. The survey will take no longer than 10 minutes to complete and the results will help us improve the website to ensure it really works for you.
CJD is one of the Transmissible Spongiform Encephalopathy (TSE) that affect man (human, homo sapien), the others are Kuru, Gerstmann Straussler Scheinker syndrome (GSS) and Fatal Familial Insomnia (FFI).
The Influenza Resource Centre (IRC) of the NIBSC has played a key role in influenza vaccine standardisation and control for over 30 years, and its scientific expertise in the field is highly respected internationally.
Stem cells are, potentially, one of the most important emerging biotherapeutic medicines. The use of stem cells holds out hope for a treatment for a range of health problems including spinal trauma, diabetes, Parkinson's disease.
Reagents are shipped globally with the primary objective being to assist and support the HIV/AIDS research community through the provision of high quality, basic and specialised biological research materials.